colistimethate sodium

co·lis·ti·meth·ate so·di·um

(kō-lis'ti-meth'āte sō'dē-ŭm),
Contains the pentasodium salt of the penta(methanesulfonic acid) derivative of colistin A as the major component, with a small proportion of the pentasodium salt of the same derivative of colistin B; an effective antibiotic against most gram-negative bacilli (except Proteus), given intramuscularly.
See also: polymyxin.
Synonym(s): cholistine sulphomethate sodium

colistimethate sodium

[kō′listim′əthāt]
an antibiotic. Also called colistin sulfomethate sodium.
indications It is prescribed in the treatment of GI infections caused by certain gram-negative microorganisms and as a topical medication.
contraindications Known hypersensitivity to this drug prohibits its use.
adverse effects Among the more serious adverse reactions are nephrotoxicity and neurotoxicity.

co·lis·ti·meth·ate so·di·um

(kō-lis'ti-meth'āte sō'dē-ŭm)
Effective antibiotic against most gram-negative bacilli (except Proteus), given intramuscularly.
Mentioned in ?
References in periodicals archive ?
J01xb01 colistimethate sodium powder for solution for injection or infusion 1 miu 50.
Supply Of Medicinal Products Divided Into Two Separate Lots According To A Technical Specification
The most common dose of colistimethate sodium is IV 50,000-75,000 units/kg/day in two divided doses, for patients with normal renal function.
Use of colistin for the treatment of multi drug resistant isolates in neonates
Public Assessment Report: Decentralised procedure: Colistimethate sodium.
Angio-oedema associated with colistin
Colistimethate sodium was administered as recommended in the literature in three equal doses of 5 mg/kg per day, 12 hours after a single 5 mg/kg loading dose.
Evaluation of risk factors for intravenous colistin use-related nephrotoxicity
Xellia is a supplier of vancomycin and colistimethate sodium which together combat multi-drug resistant bacterial infections across Gram-positive and Gram-negative species.
Xellia Pharmaceuticals Acquires Hikma Manufacturing Plant in Ohio, USA
Sol, 50-, 150-, 450- and 600; ZenChent (EE/norethindrone); colistimethate sodium inj.
Watson Pharmaceuticals, Inc
NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis patients aged 6 years and older with chronic lung infection caused by P.
Forest Laboratories Receives European Marketing Approval for Colobreathe[R] Dry Powder Inhaler
An additional problem is that prescribing units differ between manufacturers, including mg for colistin base activity (CBA) and colistimethate sodium (CMS), and international units for CMS.
Systematic review of the evidence for rational dosing of colistin
Its products, which include Vancomycin and Colistimethate Sodium (CMS), are manufactured at facilities in Denmark, Norway, Hungary and China.
Novo to buy Xellia for USD700m
Contract notice: supply of the medicines meropenem, cefepime and colistimethate sodium for intravenous and inhalation administration for all osakidetza service organizations.
Supply Of The Medicines Meropenem, Cefepime And Colistimethate Sodium For Intravenous And Inhalation Administration For All Osakidetza Service Organizations
Pharmaceutical company Forest Laboratories Inc (NYSE:FRX) announced on Friday the receipt of European Medicines Agency (EMA) approval to market Colobreathe dry powder colistimethate sodium for inhalation for treating cystic fibrosis.
Forest Laboratories wins EMA approval to market Colobreathe dry powder inhaler for cystic fibrosis
Limited Tenders are invited for Supply Of Inj Colistimethate Sodium
Supply Of Inj Colistimethate Sodium

Medical browser ?
Full browser ?